Skip to main content

Endocriniens

  • Chapter
Tumeurs malignes rares
  • 50 Accesses

Résumé

Le concept de syndrome endocrinien par production d’hormone par des tissus cancéreux n’est pas simple.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Bollanti L, Riondino G, Strollo F (2001) Endocrine paraneoplastic syndromes with special reference to the elderly. Endocrine 14: 151–7

    Article  CAS  PubMed  Google Scholar 

  2. Strewler GJ (2003) Humoral manifestations of malignancy. In Williams: Textbook of Endocrinolgy, 10e ed., sous la direction de Larsen PR, Kronenberg HM, Melmed S et Polonsky KS, Saunders Elsevier Science (USA), pp 1834–1856

    Google Scholar 

  3. Tonini G, Vincenzi B, Santini D (2006) Paraneoplastic syndromes: what we know and what we should know. Clin Ter 157: 93–4

    CAS  PubMed  Google Scholar 

  4. Clines GA, Guise TA (2005) Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 12: 549–83

    Article  CAS  PubMed  Google Scholar 

  5. Rizzoli R, Thiebaud, D, Bundred, N, et al. (1999) Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. J Clin Endocrinol Metab 84: 3545

    Article  CAS  PubMed  Google Scholar 

  6. Roodman GD (1997) Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer 80: 1557

    Article  CAS  PubMed  Google Scholar 

  7. Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352: 373–9

    Article  CAS  PubMed  Google Scholar 

  8. Strewler GJ (2000) The physiology of parathyroid hormone-related protein. N Engl J Med 342: 177

    Article  CAS  PubMed  Google Scholar 

  9. Vanhouten JN, Yu N, Rimm D, et al. (2006) Hypercalcemia of Malignancy due to Ectopic Transactivation of the Parathyroid Hormone Gene. J Clin Endocrinol Metab 91: 580

    Article  CAS  PubMed  Google Scholar 

  10. Arioglu E, Doppman J, Gomes M, et al. (1998) Cushing’s syndrome caused by corticotropin secretion by pulmonary tumorlets. N Engl J Med 339: 883

    Article  CAS  PubMed  Google Scholar 

  11. Ilias I, Torpy DJ, Pacak K, et al. (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 90: 4955

    Article  CAS  PubMed  Google Scholar 

  12. Isidori AM, Kaltsas GA, Pozza C, et al. (2006) The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91: 371

    Article  CAS  PubMed  Google Scholar 

  13. Krenning EP, Kwekkeboom DJ, Bakker WH, et al. (1993) Somatostatin receptor scintigraphy with [111In-DPTA-DPhe1]-and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20: 716

    Article  CAS  PubMed  Google Scholar 

  14. Machado MC, de Sa SV, Domenice S, et al. (2007) The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing’s syndrome. Clin Endocrinol (Oxf) 66: 136

    CAS  Google Scholar 

  15. Winquist EW, Laskey J, Crump M, et al. (1995) Ketoconazole in the management of paraneoplastic Cushing’s syndrome secondary to ectopic adrenocorticotropin production. J Clin Oncol 13: 157

    CAS  PubMed  Google Scholar 

  16. Miraki-Moud F, Grossman AB, Besser M, et al. (2005) A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. J Clin Endocrinol Metab 90: 3819–23

    Article  CAS  PubMed  Google Scholar 

  17. Nauck MA, Reinecke M, Perren A, et al. (2007) Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. J Clin Endocrinol Metab 92: 1600–5

    Article  CAS  PubMed  Google Scholar 

  18. Adrogue HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342: 1581–9

    Article  CAS  PubMed  Google Scholar 

  19. Ellison DH, Berl T (2007) Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356: 2064–72

    Article  CAS  PubMed  Google Scholar 

  20. Verbalis JG, Goldsmith SR, Greenberg A et al. (2007) Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 120: S1–21

    Article  Google Scholar 

  21. Biermasz NR, Smit JW, Pereira AM, et al. (2007) Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients. Pituitary 10: 237–49

    Article  PubMed  Google Scholar 

  22. Losa M, von Werder K (1997) Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome. Clin Endocrinol (Oxf) 47: 123–35

    Article  CAS  Google Scholar 

  23. Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355: 2558–73

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Orgiazzi, J. (2010). Endocriniens. In: Tumeurs malignes rares. Springer, Paris. https://doi.org/10.1007/978-2-287-72070-3_46

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72070-3_46

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72069-7

  • Online ISBN: 978-2-287-72070-3

Publish with us

Policies and ethics